VEGF Modulation is the clinical strategy of regulating the activity of Vascular Endothelial Growth Factor (VEGF), a potent signaling protein that stimulates the formation of new blood vessels (angiogenesis) and maintains the health of existing vascular structures. Appropriate modulation is critical for promoting tissue healing, enhancing oxygen and nutrient delivery to muscle and brain tissue, and maintaining optimal endothelial function. Dysregulation, however, can contribute to pathological conditions.
Origin
The term originates in molecular biology and oncology, where VEGF was initially studied for its role in tumor growth, but its therapeutic potential has been extended to regenerative medicine and cardiovascular health. Modulation signifies a precise clinical control of its concentration and receptor signaling.
Mechanism
VEGF exerts its effects by binding to specific receptor tyrosine kinases, primarily VEGFR-1 and VEGFR-2, on endothelial cells, triggering a cascade that promotes cell migration, proliferation, and survival. Hormones, particularly estrogen and testosterone, are known to be endogenous modulators of VEGF expression. Therapeutic modulation aims to upregulate beneficial angiogenesis in ischemic tissues while controlling its overall activity for systemic health benefits.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.